Healthcare

  The global microRNA market size is expected to showcase exponential growth by reaching USD 613.2 million by 2027 while exhibiting a CAGR of 13.4% between 2020 and 2027. This growth is attributable to the increasing prevalence of chronic diseases such as Cancer and the growing focus on adoption of advanced technology in microRNA research across the globe. This information is published by Fortune Business Insights in its latest report, titled,   “MicroRNA Market Size, Share & Covid-19 Impact Analysis, By Product (Instruments and Kits & Reagents) By Application (Isolation & Purification, Detection & Quantification, Disease Diagnostics, and Others) and By End User (Pharma & Biotech Companies, Academic & Research Institutes, Healthcare Facilities, and Others), 2020-2027.”  The report further mentions that the market stood at USD 215.4 million in 2019. For more information in the analysis of this report, visit:  https://www.fortunebusinessinsights...

  The Global Thrombin Market is supported by the rising rate of thrombosis among individuals, all around. The fatal nature of thrombosis and use of thrombin to trump thrombosis is emphasized in Fortune Business Insights’ latest report, titled “Thrombin Market: Global Analysis, Insights and Forecasts, 2019-2026.” Browse Complete Report Details: https://www.fortunebusinessinsights.com/industry-reports/thrombin-market-100170 In the report, Fortune Business Insights has briefed that an increasing emphasis on clinical trials of thrombin has boosted the global market, and it is estimated to expand at a CAGR of 4.1%. As of 2018, The Global Thrombin Market has valued at US$ 535.0 Mn, and the forecasted CAGR means that this market will be valued at around US$ 738.7 Mn by the end of 2025. Leading Players operating in the Thrombin Market are:   Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innova...

  The global anticoagulants market size is projected to reach 45.50 billion by the end of 2026. According to a report published by Fortune Business Insights, titled “Anticoagulants Market Size, Share & Industry Analysis, By Disease Indication (Pulmonary Embolism (PE), Deep Vein Thrombosis (DVT), Atrial Fibrillation, Heart Attacks, Others), By Route of Administration (Oral, Injectable), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019-2026,” the market was worth USD 21.45 billion in 2018 and will exhibit a CAGR of 9.9% during the forecast period,2019-2026. For more information in the analysis of this report, visit:   https://www.fortunebusinessinsights.com/industry-reports/anticoagulants-market-101807 Anticoagulants are widely used across the healthcare industry for the treatment of several cardiovascular and health-related disorders. They are effectively used to treat blood clots avoid blockage of bloo...